157 related articles for article (PubMed ID: 35387442)
1. Usefulness of Platelet Distribution Width and Fibrinogen in Predicting In-stent Restenosis With Stable Angina and Type 2 Patients With Diabetes Mellitus.
Chai D; Yang X; Wang A; Lu S; Dai Y; Zhou J
Front Cardiovasc Med; 2022; 9():710804. PubMed ID: 35387442
[TBL] [Abstract][Full Text] [Related]
2. Platelet Distribution Width on Admission Predicts In-Stent Restenosis in Patients with Coronary Artery Disease and Type 2 Diabetes Mellitus Treated with Percutaneous Coronary Intervention.
Hu CP; Du Y; Zhu Y; Shi C; Qin Z; Zhao YX
Chin Med J (Engl); 2018 Apr; 131(7):757-763. PubMed ID: 29578117
[TBL] [Abstract][Full Text] [Related]
3. Role of red blood cell distribution in predicting drug-eluting stent restenosis in patients with stable angina pectoris after coronary stenting.
Zhao K; Li YJ; Gao S
Coron Artery Dis; 2015 May; 26(3):220-4. PubMed ID: 25647458
[TBL] [Abstract][Full Text] [Related]
4. A prediction model based on platelet parameters, lipid levels, and angiographic characteristics to predict in-stent restenosis in coronary artery disease patients implanted with drug-eluting stents.
Gai MT; Zhu B; Chen XC; Liu F; Xie X; Gao XM; Ma X; Fu ZY; Ma YT; Chen BD
Lipids Health Dis; 2021 Sep; 20(1):118. PubMed ID: 34587955
[TBL] [Abstract][Full Text] [Related]
5. The value of peripheral blood eosinophil count in predicting in-stent restenosis in patients with stable angina pectoris undergoing drug eluting stenting.
Hajizadeh R; Ghaffari S; Separham A; Shokouhi B; Kavandi H; Pourafkari L; Nader ND
Rom J Intern Med; 2017 Dec; 55(4):229-236. PubMed ID: 28672766
[TBL] [Abstract][Full Text] [Related]
6. The relationship between fibrinogen-to-albumin ratio and in-stent restenosis in patients with coronary artery disease undergoing drug-eluting stenting.
Chen T; Sun JL; Zhang J
Coron Artery Dis; 2020 Nov; 31(7):586-589. PubMed ID: 32271235
[TBL] [Abstract][Full Text] [Related]
7. A Novel Score for an Old Enemy: Atherogenic Plasma Index Predicts In-Stent Restenosis among Stable Angina Pectoris Patients.
Ser OS; Sigirci S; Keskin K; Cetinkal G; Kocas BB; Kilci H; Dalgic Y; Kalender E; Kilickesmez K
Sisli Etfal Hastan Tip Bul; 2024; 58(1):75-81. PubMed ID: 38808058
[TBL] [Abstract][Full Text] [Related]
8. Effect of diabetes mellitus on long-term outcomes after repeat drug-eluting stent implantation for in-stent restenosis.
Zhao L; Zhu W; Zhang X; He D; Guo C
BMC Cardiovasc Disord; 2017 Jan; 17(1):16. PubMed ID: 28061808
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of preprocedural levels of advanced glycation end products to predict restenosis in patients with controlled diabetes mellitus undergoing drug-eluting stent implantation for stable angina pectoris (from the Prospective ARMYDA-AGEs Study).
Spadaccio C; Patti G; De Marco F; Coccia R; Di Domenico F; Pollari F; Zanzonico R; Pettinari M; Lusini M; Di Sciascio G; Covino E; Chello M
Am J Cardiol; 2013 Jul; 112(1):21-6. PubMed ID: 23561587
[TBL] [Abstract][Full Text] [Related]
10. Switching types of drug-eluting stents does not prevent repeated in-stent restenosis in patients with coronary drug-eluting stent restenosis.
Nojima Y; Yasuoka Y; Kume K; Adachi H; Hattori S; Matsutera R; Kohama Y; Sasaki T
Coron Artery Dis; 2014 Dec; 25(8):638-44. PubMed ID: 25076360
[TBL] [Abstract][Full Text] [Related]
11. New predictors of in-stent restenosis in patients with diabetes mellitus undergoing percutaneous coronary intervention with drug-eluting stent.
Wang JL; Qin Z; Wang ZJ; Shi DM; Liu YY; Zhao YX; Yang LX; Cheng WJ; Zhou YJ
J Geriatr Cardiol; 2018 Feb; 15(2):137-145. PubMed ID: 29662507
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcomes of the Resolute zotarolimus-eluting stent in patients with in-stent restenosis: 2-year results from a pooled analysis.
Richardt G; Leschke M; Abdel-Wahab M; Toelg R; El-Mawardy M; Serruys PW; Silber S; Windecker S; Belardi JA; Neumann FJ; Widimsky P; ;
JACC Cardiovasc Interv; 2013 Sep; 6(9):905-13. PubMed ID: 23954063
[TBL] [Abstract][Full Text] [Related]
13. [Predictors of in-stent restenosis in coronary heart disease patients complicating with diabetes mellitus within 2 years after drug-eluting stents implantation].
Chen J; Chen Y; Tian F; Han Y; Jing J; Liu J; Wang J; Zhou S
Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Jan; 42(1):14-8. PubMed ID: 24680263
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for revascularization and in-stent restenosis in patients with triple-vessel disease after second-generation drug-eluting stent implantation: a retrospective analysis.
Zeng M; Yan X; Wu W
BMC Cardiovasc Disord; 2021 Sep; 21(1):446. PubMed ID: 34535088
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of everolimus-eluting stents in the treatment of drug-eluting stent versus bare-metal stent restenosis.
Almalla M; Pross V; Marx N; Hoffmann R
Coron Artery Dis; 2012 Nov; 23(7):492-6. PubMed ID: 22990414
[TBL] [Abstract][Full Text] [Related]
16. The value of serum visfatin in predicting in-stent restenosis of drug-eluting stents.
Wu XA; Xie G; Li XQ; Wu HT; Wang X
Clin Chim Acta; 2018 Apr; 479():20-24. PubMed ID: 29305846
[TBL] [Abstract][Full Text] [Related]
17. Value of S100A12 in predicting in-stent restenosis in patients with coronary drug-eluting stent implantation.
Liang H; Cui Y; Bu H; Liu H; Yan P; Cui L; Chen L
Exp Ther Med; 2020 Jul; 20(1):211-218. PubMed ID: 32536993
[TBL] [Abstract][Full Text] [Related]
18. CHA
Zhao SG; Xu JJ; Tao ZH; Jin L; Liu Q; Zheng WY; Jiang LQ; Wang NF
J Int Med Res; 2019 Jun; 47(6):2533-2544. PubMed ID: 31039653
[TBL] [Abstract][Full Text] [Related]
19. Remnant Lipoprotein Cholesterol Independently Associates With In-Stent Restenosis After Drug-Eluting Stenting for Coronary Artery Disease.
Xu X; Pandit RU; Han L; Li Y; Guo X
Angiology; 2019 Oct; 70(9):853-859. PubMed ID: 31167539
[TBL] [Abstract][Full Text] [Related]
20. Red cell distribution width in coronary heart disease: prediction of restenosis and its relationship with inflammatory markers and lipids.
Qian H; Luo Z; Xiao C; Chen J; Li D; Xu H; He P; Zhou X; Zhang T; Min X
Postgrad Med J; 2018 Sep; 94(1115):489-494. PubMed ID: 30301834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
